Reduced angiogenesis and delay in wound healing in angiotensin II type 1a receptor-deficient mice

Biomedicine and Pharmacotherapy

Volumn 63, Issue 9, 2009, Pages 627-634

  Kurosaka, Maya ^a   Suzuki, Tatsunori ^a   Hosono, Kanako ^a   Kamata, Yuji ^a   Fukamizu, Akiyoshi ^b   Kitasato, Hidero ^c   Fujita, Yoshikuni ^a   Majima, Masataka ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Angiotensin II; Wound healing

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN II; CANDESARTAN HEXETIL; CD31 ANTIGEN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GRANULATION TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WOUND CLOSURE; WOUND HEALING;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIGENS, CD31; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR, ANGIOTENSIN, TYPE 1; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 72649098844     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2009.01.001     Document Type: Article

References (27)

1. Castro-Chaves P., and Leite-Moreira A.F. Renin-angiotensin system and its role in cardiovascular physiopathology and therapy. Rev Port Cardiol 23 Suppl. 2 (2004) II61-II77
2. Miyazaki M., and Takai S. Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase. J Pharmacol Sci 100 5 (2006) 391-397
3. Colville-Nash P.R., and Scott D.L. Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann Rheum Dis 51 (1992) 919-925
4. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1 1 (1995) 27-31
5. Kamoshita E., Ikeda Y., Fujita M., Amano H., Oikawa A., Suzuki T., et al. Recruitment of a prostaglandin E receptor subtype, EP3-expressing bone marrow cells is crucial in wound-induced angiogenesis. Am J Pathol 169 (2006) 1458-1472
6. Kuma S., Oki E., Onohara T., and Maehara Y. Angiotensin II-induced growth of vascular smooth muscle cells is associated with modulation of cell surface area and platelet-derived growth factor receptor expression. Clin Exp Pharmacol Physiol 34 3 (2007) 153-160
7. Bell L., and Madri J.A. Influence of the angiotensin system on endothelial and smooth muscle cell migration. Am J Pathol 137 (1990) 7-12
8. Otani A., Takagi H., Oh H., Suzuma K., Matsumura M., Ikeda E., et al. Angiotensin II-stimulated vascular endothelial growth factor expression in bovine retinal pericytes. Invest Ophthalmol Vis Sci 41 (2000) 1192-1199
9. Nadal J.A., Scicli G.M., Carbini L.A., Nussbaum J.J., and Scicli A.G. Angiotensin II and retinal pericytes migration. Biochem Biophys Res Commun 266 2 (1999) 382-385
10. Tamarat R., Silvestre J.S., Durie M., and Levy B.I. Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab Invest 82 6 (2002) 747-756
11. Le Noble F.A., Hekking J.W., Van Straaten H.W., Slaaf D.W., and Struyker Boudier H.A. Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur J Pharmacol 195 2 (1991) 305-306
12. Nagai N., Oike Y., Izumi-Nagai K., Koto T., Satofuka S., Shinoda H., et al. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin. Invest Ophthalmol Vis Sci 48 5 (2007) 2321-2326
13. Andrade S.P., Cardoso C.C., Machado R.D., and Beraldo W.T. Angiotensin-II-induced angiogenesis in sponge implants in mice. Int J Microcirc Clin Exp 16 6 (1996) 302-307
14. Sasaki K., Murohara T., Ikeda H., Sugaya T., Shimada T., Shintani S., et al. Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J Clin Invest 109 5 (2002) 603-611
15. Muramatsu M., Katada J., Hayashi I., and Majima M. Chymase as a proangiogenic factor. J Biol Chem 275 8 (2000) 5545-5552
16. Katada J., Muramatsu M., Hayashi I., and Majima M. Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas. J Pharmacol Exp Ther 302 3 (2002) 949-956
17. Fujita M., Hayashi I., Yamashina S., Fukamizu A., Itoman M., and Majima M. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis 26 2 (2005) 271-279
18. Sugaya T., Nishimatsu S., Tanimoto K., Takimoto E., Yamagishi T., Imamura K., et al. Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem 270 32 (1995) 18719-18722
19. Fujita M., Hayashi I., Yamashita S., Itoman M., and Majima M. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun 294 2 (2002) 441-447
20. Singer A.J., and Clark R.A. Cutaneous wound healing. N Engl J Med 341 10 (1999) 738-746
21. Toda M., Suzuki T., Hosono K., Kurihara Y., Kurihara H., Hayashi I., et al. Roles of calcitonin gene-related peptide in facilitation of wound healing and angiogenesis. Biomed Pharmacother 62 6 (2008) 352-359
22. Shweiki D., Itin A., Neufeld G., Gitay-Goren H., and Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 91 5 (1993) 2235-2243
23. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 (2003) 669-676
24. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25 4 (2004) 581-611
25. Chua C.C., Hamdy R.C., and Chua B.H. Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. Biochim Biophys Acta 1401 2 (1998) 187-194
26. Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J.C., et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266 18 (1991) 11947-11954
27. Shima D.T., Kuroki M., Deutsch U., Ng Y.S., Adamis A.P., and D'Amore P.A. The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J Biol Chem 271 7 (1996) 3877-3883